Decision-making during the COVID-19 pandemic
COVID-19 series — installment #2: RIKEN CBS Unit Leader Rei Akaishi talks about government decision-making during the pandemic.
Mar 18
COVID-19 series — installment #2: RIKEN CBS Unit Leader Rei Akaishi talks about government decision-making during the pandemic.
Mar 5
Confronting a string of epidemics including COVID-19
COVID-19 series — installment #1: RIKEN Executive Director Shigeo Koyasu talks about epidemics and what a good response looks like.
Feb 19
Next stop: clinical hair regeneration
A new recipe for continuous cyclical hair regeneration in mice. This means that the hair will continue to fall out and regrow like normal hair.
Nov 26
Bacterial drug resistance studied by robotic E. coli evolution
Experimentally evolving E. coli under pressure from a large number of antibiotics was able to identify constraints underlying evolved drug resistance.
Nov 9
New artificial skin helps avoid animal testing
A new artificial skin that reproduces proper tension can be used to research skin function and disease while reducing the need to experiment on animals.
Sep 11
FABP4: A preschool-aged biomarker for autism
Reduced FABP4 was found in preschool-aged children with autism spectrum disorder, making it a potential new biomarker for the condition.
RIKEN at a Glance
30-day trend
- April 2, 2024
Detecting pathogens: the evolution of plant immunity - November 26, 2020
Bacterial drug resistance studied by robotic E. coli evolution - February 15, 2022
Green hydrogen production for fuel cells and fertilizers - April 3, 2024
Gut bacteria could help overcome milk allergy - March 21, 2024
Genomic “butterfly effect” involving TADs explains risk for autism
Topics
